Searched for
SUBLINGUAL TABLETS
AIIMS doctor warns: Pure veg eaters could face important vitamin deficiency due to diet. How to fix it?An AIIMS Delhi neurologist has warned that pure vegetarians are naturally more prone to vitamin B12 deficiency because plants do not produc...- Vitamin B12 veg or non-veg? Apollo doctor explains why India tops it's deficiency list. 3 solutions to fix itVitamin B12, essential for red blood cell formation and nerve health, is often mistakenly considered a “non-vegetarian vitamin.” Apollo Hos...
- Can diet make you feel tired? Early warning signs your body is vitamin B12 deficient. Here's what to doPersistent fatigue, mental fog, and weakness may be more than just signs of a busy lifestyle—they can indicate a vitamin B12 deficiency. Es...
- Feeling Drained? Here’s the best time and way to take vitamin B12 for maximum energy and better healthMaximizing Vitamin B12 benefits hinges on optimal intake timing and methods. Experts suggest taking B12 supplements on an empty stomach, id...
- Rusan Pharma opens new API facility in Pithampur with Rs 300 crore investmentMumbai-based drug manufacturer Rusan Pharma has inaugurated a new active pharmaceutical ingredient (API) facility in Pithampur, Madhya Prad...
- Heart Attacks: Signs, Aspirin cure and its dosage. Here are life-saving tips from DoctorsA recent study presented at the ESC Congress 2023 highlighted the importance of taking aspirin after a heart attack. The study found that i...
- Allergy signs overlapping with Covid symptoms? Guide to fight stuffy noses & scratchy throatsYou cannot avoid pollen entirely, but there are ways to prevent symptoms.
- Zydus Lifesciences up 2% on USFDA nod to market Nitroglycerin Sublingual tabletsZydus Lifesciences’ scrip climbed to a high of Rs 368 as against the previous close of Rs 359.35 on the National Stock Exchange. The stock ...
- Stocks in the news: Airtel, NTPC, Raymond, L&T and Tata PowerL&T Construction, the construction infrastructure arm of L&T, has won a significant order from Delhi Metro Rail Corporation to design and c...
- SEC suggests approval for remdesivir in tablet formRemdesivir is currently administered in the country through intravenous route.
- Alembic Pharma gets USFDA nod for bipolar disorder treatment drugIn a regulatory filing, Alembic Pharmaceuticals said it has received approval from the US Food and Drug Administration (USFDA) for its abbr...
- Jubilant Life Sciences seeks nod to roll out Remdesivir tabletAccording to the proposal, the company is exploring the possibility of launching 20 mg sublingual tablets. Sublingual administration involv...
- 6 steps to take when you see someone having a heart attackOn World Heart Day, know the signs when someone is having a heart attack.
- Natco Pharma's marketing partner gets USFDA approval for chest pain tabletsNitroglycerin Sublingual Tablets had total annual sales of around USD 77.3 million.
- Glenmark gets USFDA nod for chest pain tabletsGlenmark Pharmaceuticals Inc has received final approval by the US health regulator for Nitroglycerin sublingual tablets USP in the strengt...
- Fifteen stocks in focus on Tuesday, 30 August 2016The Indian market is expected to open higher. Here is a list of top fifteen stocks that are likely to be in focus today.
- DRL launches nitroglycerin sublingual tablets in USThe drug which is used in preventing or relieving a sudden attack of angina (chest pain) caused by heart disease was approved by the USFDA.
- Lupin launches generic insomnia drug in USDrug major Lupin has launched a generic insomnia drug, Zolpidem Sublingual tablets, in the US market with 180-days of marketing exclusivity.
Load More
